FindTrial
Sign In

Efficacy of Che-Re-Cun-Jin Decoction for the treatment of Primary Sjogren's Syndrome

Diagnosis and treatment of Sjogren's syndrome by Che-Re-Cun-Jin Decoction and its application

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016471
Enrollment
Unknown
Registered
2018-06-02
Start date
2018-06-04
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's syndrome

Interventions

observation group:Che-Re-Cun-Jin decoction +HCQ
control group:HCQ

Sponsors

Chongqing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) To meet the 2016ACR / EULAR classification criteria for pSS; (2) The TCM syndrome was dryness-heat due to yin deficiency syndrome; (3) aged from 18 to 70 years; (4) ESSDAI score before treatment<5; (5) signed the written informed consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: (1) diagnosed with Secondary Sjogrens syndrome; (2) Have systemic disorders recently (lymphoma; central nervous system, renal, or pulmonary involvement; myositis; or vasculitis) or severe renal or liver failure; (3) pregnancy or lactation in female patients; (4) patients with drug allergies; (5) patients that used other Chinese herbal medicines within two weeks; (6) Subjects with a physical or psychological problem, which may confound the trial results, interfere with other subjects participation, or may make it risky to follow the investigators requirements.

Design outcomes

Primary

MeasureTime frame
TCM symptom integrals;—

Countries

China

Contacts

Public ContactBin Wu

Chongqing Hospital of Traditional Chinese Medicine

wuubinn@126.com+86 023-67713784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026